Article Versions Notes

Yarur AJ, Dervieux T, Ungaro R, Spencer EA, Bruss A, Nunez L, Berens B, Vermeire S, Wang Z, Panetta JC, et al. Ustekinumab Drug Clearance Is Better Associated with Disease Control than Serum Trough Concentrations in a Prospective Cohort of Inflammatory Bowel Disease. Pharmaceutics. 2025; 17(2):187. https://doi.org/10.3390/pharmaceutics17020187

Yarur, Andres J., Thierry Dervieux, Ryan Ungaro, Elizabeth A. Spencer, Alexandra Bruss, Lizbeth Nunez, Brandon Berens, Séverine Vermeire, Zhigang Wang, John C. Panetta, and et al. 2025. "Ustekinumab Drug Clearance Is Better Associated with Disease Control than Serum Trough Concentrations in a Prospective Cohort of Inflammatory Bowel Disease" Pharmaceutics 17, no. 2: 187. https://doi.org/10.3390/pharmaceutics17020187

Yarur, A. J., Dervieux, T., Ungaro, R., Spencer, E. A., Bruss, A., Nunez, L., Berens, B., Vermeire, S., Wang, Z., Panetta, J. C., Dreesen, E., & Dubinsky, M. C. (2025). Ustekinumab Drug Clearance Is Better Associated with Disease Control than Serum Trough Concentrations in a Prospective Cohort of Inflammatory Bowel Disease. Pharmaceutics, 17(2), 187. https://doi.org/10.3390/pharmaceutics17020187